These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women. Gokkusu C, Tata G, Ademoğlu E, Tamer S. Platelets; 2010; 21(6):439-44. PubMed ID: 20459351 [Abstract] [Full Text] [Related]
30. Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women. Roussel AM, Bureau I, Favier M, Polansky MM, Bryden NA, Anderson RA. Maturitas; 2002 May 20; 42(1):63-9. PubMed ID: 12020981 [Abstract] [Full Text] [Related]
34. No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. Bureau I, Laporte F, Favier M, Faure H, Fields M, Favier AE, Roussel AM. J Am Coll Nutr; 2002 Aug 20; 21(4):333-8. PubMed ID: 12166530 [Abstract] [Full Text] [Related]
35. The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial. Manning PJ, Allum A, Jones S, Sutherland WH, Williams SM. Arch Intern Med; 2001 Jul 23; 161(14):1772-6. PubMed ID: 11485511 [Abstract] [Full Text] [Related]
36. Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy. Wander RC, Du SH, Ketchum SO, Rowe KE. Am J Clin Nutr; 1996 Feb 23; 63(2):184-93. PubMed ID: 8561059 [Abstract] [Full Text] [Related]
37. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Scott AR, Dhindsa P, Forsyth J, Mansell P, Kliofem Study Collaborative Group. Diabetes Obes Metab; 2004 Jan 23; 6(1):16-22. PubMed ID: 14686958 [Abstract] [Full Text] [Related]
38. Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Kernohan AF, Sattar N, Hilditch T, Cleland SJ, Small M, Lumsden MA, Connell JM, Petrie JR. Clin Endocrinol (Oxf); 2007 Jan 23; 66(1):27-34. PubMed ID: 17201798 [Abstract] [Full Text] [Related]
39. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV. Diabetes Care; 1999 Sep 23; 22(9):1401-7. PubMed ID: 10480500 [Abstract] [Full Text] [Related]
40. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA, Farias ML, Andrade AT. Climacteric; 2002 Sep 23; 5(3):286-92. PubMed ID: 12419087 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]